Abstract
ABSTRACT Bone adhesives, a new promising sort of clinical treatment for bone fractures, despite all the advantages, are concerned with cytotoxicity, mechanical strength, and fixation in the wet body environment. A procedure using Polyvinyl Alcohol and an excellent adhesion agent, Dihydroxyphenylalanine incorporated with hydroxyapatite and bioactive glass particles designed to meet a bone adhesive’s requirements. Improved wet adhesion strength, 20.5 MPa tensile strength for highly comminuted bone fractures, 99.97% cell viability alongside resistance against both gram-negative and gram-positive bacteria, and controllable biodegradation indicated that the synthesized bone adhesive is of great potential for highly comminuted bone fractures.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.